nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
2001 |
SP-0570: Neuroendocrine tumours - personalised diagnosis and treatment using radiolabelled peptides
|
Baum, R.P. |
|
2016 |
119 |
S1 |
p. S274-S275 2 p. |
artikel |
2002 |
SP-0109: New avenues for training with e-learning
|
Tan, L.T. |
|
2016 |
119 |
S1 |
p. S50- 1 p. |
artikel |
2003 |
SP-0497: New concepts for lymphoma radiotherapy and the use of advanced technology
|
Specht, L. |
|
2016 |
119 |
S1 |
p. S236- 1 p. |
artikel |
2004 |
SP-0027: New IAEA-AAPM Code of Practice for dosimetry of small photon fields used in external beam radiotherapy
|
Palmans, H. |
|
2016 |
119 |
S1 |
p. S10-S11 2 p. |
artikel |
2005 |
SP-0605: New strategies to targeting tumour angiogenesis and hypoxia
|
Chinot, O. |
|
2016 |
119 |
S1 |
p. S290- 1 p. |
artikel |
2006 |
SP-0204: New techniques in brachytherapy for head and neck
|
Kovács, G. |
|
2016 |
119 |
S1 |
p. S93- 1 p. |
artikel |
2007 |
SP-0578: New technologies for genomic tumour profiling
|
Weichert, W. |
|
2016 |
119 |
S1 |
p. S277- 1 p. |
artikel |
2008 |
SP-0004: New tools to reduce toxicity in pelvic radiation
|
Joye, I. |
|
2016 |
119 |
S1 |
p. S1-S2 2 p. |
artikel |
2009 |
SP-0611: Normal tissue response in particle therapy
|
Sørensen, B.S. |
|
2016 |
119 |
S1 |
p. S291-S292 2 p. |
artikel |
2010 |
SP-0577: Novel insights in radioresistance of head and neck cancer
|
Tinhofer-Keilholz, I. |
|
2016 |
119 |
S1 |
p. S277- 1 p. |
artikel |
2011 |
SP-0574: Optimising workflow in a radiotherapy department - an introduction to lean thinking
|
Naddy, B. |
|
2016 |
119 |
S1 |
p. S276- 1 p. |
artikel |
2012 |
SP-0600: Optimising workflow using a workflow management system
|
Vaandering, A. |
|
2016 |
119 |
S1 |
p. S287- 1 p. |
artikel |
2013 |
SP-0616: Organ motion: is it an obstacle to the use of IMRT as a standard technique for gynecological cancers?
|
Barillot, I. |
|
2016 |
119 |
S1 |
p. S293- 1 p. |
artikel |
2014 |
SP-0098: Organoids, a disease and patient specific in vitro model system
|
Vries, R. |
|
2016 |
119 |
S1 |
p. S45-S46 2 p. |
artikel |
2015 |
SP-0392: Overview of clinical practice of ART for pelvic tumours
|
Thörnqvist, S. |
|
2016 |
119 |
S1 |
p. S183-S184 2 p. |
artikel |
2016 |
SP-0316: Palliative radiation therapy in geriatric cancer patients
|
Nieder, C. |
|
2016 |
119 |
S1 |
p. S146- 1 p. |
artikel |
2017 |
SP-0003: Partial Breast Irradiation: who, when and how?
|
Coles, C. |
|
2016 |
119 |
S1 |
p. S1- 1 p. |
artikel |
2018 |
SP-0200: Partial nefrectomy: indication and results
|
Gontero, P. |
|
2016 |
119 |
S1 |
p. S91-S92 2 p. |
artikel |
2019 |
SP-0092: Patient centric approach: myth or fact?
|
Poortmans, P. |
|
2016 |
119 |
S1 |
p. S44- 1 p. |
artikel |
2020 |
SP-0009: Patient selection for proton therapy: a clinicians view
|
Mahajan, A. |
|
2016 |
119 |
S1 |
p. S4- 1 p. |
artikel |
2021 |
SP-0007: Patient specific quality assurance in proton therapy
|
Amos, R. |
|
2016 |
119 |
S1 |
p. S3- 1 p. |
artikel |
2022 |
SP-0487: Patient's Perspective
|
Naessens, E. |
|
2016 |
119 |
S1 |
p. S233- 1 p. |
artikel |
2023 |
SP-0607: PET/CT heterogeneity quantification through texture analysis: potential role for prognostic and predictive models
|
Hatt, M. |
|
2016 |
119 |
S1 |
p. S290- 1 p. |
artikel |
2024 |
SP-0298: Phase I Results of PARPi (Olaparib) + RT + Cetuximab in LAHNSCC
|
Raben, D. |
|
2016 |
119 |
S1 |
p. S138-S139 2 p. |
artikel |
2025 |
SP-0041: Physical advantages of particles: protons vs. heavy ions, what is certain what is not?
|
Jäkel, O. |
|
2016 |
119 |
S1 |
p. S17- 1 p. |
artikel |
2026 |
SP-0107: Physician training in contouring
|
Petric, P. |
|
2016 |
119 |
S1 |
p. S49-S50 2 p. |
artikel |
2027 |
SP-0108: Physicist training in 3D dose planning
|
Bownes, P. |
|
2016 |
119 |
S1 |
p. S50- 1 p. |
artikel |
2028 |
SP-0619: PotD external beam: overview of current practice
|
Penninkhof, J. |
|
2016 |
119 |
S1 |
p. S294-S295 2 p. |
artikel |
2029 |
SP-0293: Potentials and challenges of automated contouring in treatment planning
|
Pallotta, S. |
|
2016 |
119 |
S1 |
p. S136- 1 p. |
artikel |
2030 |
SP-0095: Pre-clinical and clinical data on the radiobiological mechanism for the efficacy of SABR
|
Brown, M. |
|
2016 |
119 |
S1 |
p. S44-S45 2 p. |
artikel |
2031 |
SP-0504: Preclinical radiotherapy technology, dosimetry and treatment planning
|
Butterworth, K. |
|
2016 |
119 |
S1 |
p. S238-S239 2 p. |
artikel |
2032 |
SP-0612: Preclinical studies using protons for high-precision irradiation of small animals
|
Van Luijk, P. |
|
2016 |
119 |
S1 |
p. S292- 1 p. |
artikel |
2033 |
SP-0397: Predicting cardiac toxicity after breast irradiation: new quantitative data and new challenges
|
Gagliardi, G. |
|
2016 |
119 |
S1 |
p. S186- 1 p. |
artikel |
2034 |
SP-0410: Proton therapy in HNSCC: better than IMRT?
|
Rasch, C. |
|
2016 |
119 |
S1 |
p. S191- 1 p. |
artikel |
2035 |
SP-0220: Publishing the science of radiation oncology: the perspective of the Red Journal's editor
|
Zietman, A. |
|
2016 |
119 |
S1 |
p. S100- 1 p. |
artikel |
2036 |
SP-0505: Radiation biology studies with a small animal irradiator: results from the Research Programme at Johns Hopkins University
|
Tran, P. |
|
2016 |
119 |
S1 |
p. S239- 1 p. |
artikel |
2037 |
SP-0014: Radiation-induced lung fibrosis is associated with M2 interstitial and hybrid alveolar macrophages
|
Meziani, L. |
|
2016 |
119 |
S1 |
p. S6- 1 p. |
artikel |
2038 |
SP-0013: Radiation-induced musculosqueletic late damages: possible clinical cure or simple mitigation?
|
Delanian, S. |
|
2016 |
119 |
S1 |
p. S5-S6 2 p. |
artikel |
2039 |
SP-0100: Radiation sensitivity of human skin stem cells : dissecting epigenetic effects of radiation
|
Martin, M. |
|
2016 |
119 |
S1 |
p. S46- 1 p. |
artikel |
2040 |
SP-0102: Radiation treatment intensification
|
Belderbos, J. |
|
2016 |
119 |
S1 |
p. S47- 1 p. |
artikel |
2041 |
SP-0042: Radiobiological benefits of protons and heavy ions - advantages and disadvantages
|
Karger, C.P. |
|
2016 |
119 |
S1 |
p. S17- 1 p. |
artikel |
2042 |
SP-0183: Radiotherapy and immune-therapy, biological basis and potential for future clinical trials
|
Deutsch, E. |
|
2016 |
119 |
S1 |
p. S86- 1 p. |
artikel |
2043 |
SP-0575: Radiotherapy combined with immunotherapy: present status and future perspectives
|
Lambin, P. |
|
2016 |
119 |
S1 |
p. S276-S277 2 p. |
artikel |
2044 |
SP-0591: Radiotherapy for immunotherapy: optimizing the doses and fractionation
|
Demaria, S. |
|
2016 |
119 |
S1 |
p. S283-S284 2 p. |
artikel |
2045 |
SP-0571: Radiotherapy for paediatric brain tumours
|
Kortmann, R.D. |
|
2016 |
119 |
S1 |
p. S275- 1 p. |
artikel |
2046 |
SP-0436: Radiotherapy-related second cancer risks from epidemiological studies, and their application to newer therapies
|
Berrington de González, A. |
|
2016 |
119 |
S1 |
p. S203- 1 p. |
artikel |
2047 |
SP-0586: Radiotherapy supports tumour-specific immunity
|
Van den Broek, M. |
|
2016 |
119 |
S1 |
p. S281- 1 p. |
artikel |
2048 |
SP-0196: Realising the full potential of DNA damage response inhibition in the treatment of cancer
|
Galbraith, S. |
|
2016 |
119 |
S1 |
p. S90- 1 p. |
artikel |
2049 |
SP-0613: Recent progresses in interventional radiology
|
Bize, P. |
|
2016 |
119 |
S1 |
p. S292- 1 p. |
artikel |
2050 |
SP-0020: Rectal spacers to minimise morbidity in radiotherapy for prostate cancer
|
Pinkawa, M. |
|
2016 |
119 |
S1 |
p. S8- 1 p. |
artikel |
2051 |
SP-0583: Relevance of 3D cultures to address radiation response and novel RT combination strategies
|
Cordes, N. |
|
2016 |
119 |
S1 |
p. S280- 1 p. |
artikel |
2052 |
SP-0111: Response prediction in rectal cancer using PET Radiomics
|
Leijenaar, R.T.H. |
|
2016 |
119 |
S1 |
p. S51- 1 p. |
artikel |
2053 |
SP-0203: Robotic surgery and brachytherapy
|
Pieters, B. |
|
2016 |
119 |
S1 |
p. S92-S93 2 p. |
artikel |
2054 |
SP-0572: Role and validation of deformable image registration in clinical practice
|
van Herk, M. |
|
2016 |
119 |
S1 |
p. S275-S276 2 p. |
artikel |
2055 |
SP-0005: Role of brachytherapy in the management of paediatric tumours
|
Haie-Meder, C. |
|
2016 |
119 |
S1 |
p. S2- 1 p. |
artikel |
2056 |
SP-0589: Role of systemic therapy in the treatment of brain metastases
|
Dziadziuszko, R. |
|
2016 |
119 |
S1 |
p. S282-S283 2 p. |
artikel |
2057 |
SP-0489: RTT/Nurse's perspective: patient is the key element of communication
|
Koevoets, L. |
|
2016 |
119 |
S1 |
p. S233-S234 2 p. |
artikel |
2058 |
SP-0406: SBRT for metastatic disease: how far can and should we go?
|
Dahele, M. |
|
2016 |
119 |
S1 |
p. S190- 1 p. |
artikel |
2059 |
SP-0386: SBRT/SABR for oligometastatic disease
|
Lartigau, E. |
|
2016 |
119 |
S1 |
p. S181- 1 p. |
artikel |
2060 |
SP-0010: Selection of patients for proton therapy: a physicists view
|
Hoogeman, M. |
|
2016 |
119 |
S1 |
p. S4- 1 p. |
artikel |
2061 |
SP-0384: Shared decision making
|
Tomson, D. |
|
2016 |
119 |
S1 |
p. S180- 1 p. |
artikel |
2062 |
SP-0590: Should the combined treatment be part of our field of knowledge? The "5th R," (immune-mediated) Rejection of Radiobiology
|
Lara Jimenez, P.C. |
|
2016 |
119 |
S1 |
p. S283- 1 p. |
artikel |
2063 |
SP-0292: Standardisation and treatment planning
|
Heijmen, B. |
|
2016 |
119 |
S1 |
p. S136- 1 p. |
artikel |
2064 |
SP-0201: Stereotactic radiotherapy for renal cell carcinoma: the hidden treasure or the forbidden kingdom
|
De Meerleer, G. |
|
2016 |
119 |
S1 |
p. S92- 1 p. |
artikel |
2065 |
SP-0017: Technical approaches to regional lymph node irradiation for breast cancer
|
Kirby, A. |
|
2016 |
119 |
S1 |
p. S7- 1 p. |
artikel |
2066 |
SP-0096: Technical developments in high precision radiotherapy: a new era for clinical SABR trials?
|
Aznar, M. |
|
2016 |
119 |
S1 |
p. S45- 1 p. |
artikel |
2067 |
SP-0001: Technology assessment
|
Verellen, D. |
|
2016 |
119 |
S1 |
p. S1- 1 p. |
artikel |
2068 |
SP-0568: Texture analysis of medical images in radiotherapy
|
Scalco, E. |
|
2016 |
119 |
S1 |
p. S273-S274 2 p. |
artikel |
2069 |
SP-0015: The axilla- less surgery, more radiotherapy?
|
Algara López, M.I. |
|
2016 |
119 |
S1 |
p. S6- 1 p. |
artikel |
2070 |
SP-0521: The biological rationale of dose painting: is it realistic?
|
Alber, M. |
|
2016 |
119 |
S1 |
p. S247- 1 p. |
artikel |
2071 |
SP-0321: The British Institute of Radiology
|
Hafeez, S. |
|
2016 |
119 |
S1 |
p. S147-S148 2 p. |
artikel |
2072 |
SP-0393: The challenges of ART from a physician's perspective
|
Nuyts, S. |
|
2016 |
119 |
S1 |
p. S184- 1 p. |
artikel |
2073 |
SP-0576: The contribution of cancer stem cells to tumour radioresistance
|
Chalmers, A. |
|
2016 |
119 |
S1 |
p. S277- 1 p. |
artikel |
2074 |
SP-0217: The ESTRO perspective - a guideline for positioning of head and neck patients
|
Mast, M. |
|
2016 |
119 |
S1 |
p. S99- 1 p. |
artikel |
2075 |
SP-0402: The fall and raise of predictive radiotherapy biomarkers
|
Baumann, M. |
|
2016 |
119 |
S1 |
p. S188-S189 2 p. |
artikel |
2076 |
SP-0319: The French Society of Young Radiation Oncologists
|
Leroy, T. |
|
2016 |
119 |
S1 |
p. S147- 1 p. |
artikel |
2077 |
SP-0178: The future of surgical oncology
|
Audisio, R. |
|
2016 |
119 |
S1 |
p. S85- 1 p. |
artikel |
2078 |
SP-0585: The impact of a novel 3D cell culture model of glioblastoma on radiation and drug-radiation responses
|
Gomez-Roman, N. |
|
2016 |
119 |
S1 |
p. S280-S281 2 p. |
artikel |
2079 |
SP-0602: The impact of demographics trend, cancer incidence and cancer prevalence for planning numbers of treatment unitsin Austria
|
Osztavics, A. |
|
2016 |
119 |
S1 |
p. S288-S289 2 p. |
artikel |
2080 |
SP-0016: The internal mammary chain - should we treat it in every node-positive patient?
|
Poortmans, P. |
|
2016 |
119 |
S1 |
p. S6-S7 2 p. |
artikel |
2081 |
SP-0499: The need for adaptive approaches in proton therapy (compared to photons)
|
Schwarz, M. |
|
2016 |
119 |
S1 |
p. S237- 1 p. |
artikel |
2082 |
SP-0596: The need of automation in QA, state of art and future perspectives
|
Jornet, N. |
|
2016 |
119 |
S1 |
p. S285- 1 p. |
artikel |
2083 |
SP-0567: The new 'R's; in radiation biology
|
De Jong, M.C. |
|
2016 |
119 |
S1 |
p. S273- 1 p. |
artikel |
2084 |
SP-0191: The patient: an active partner in quality and safety process in radiotherapy
|
Cucchiaro, S. |
|
2016 |
119 |
S1 |
p. S88-S89 2 p. |
artikel |
2085 |
SP-0584: The potential of normal tissue organoid cultures
|
Coppes, R.P. |
|
2016 |
119 |
S1 |
p. S280- 1 p. |
artikel |
2086 |
SP-0608: The potential of radiomics for radiotherapy individualisation
|
Troost, E. |
|
2016 |
119 |
S1 |
p. S290- 1 p. |
artikel |
2087 |
SP-0394: The practical "costs" of adaptive radiotherapy
|
Rowbottom, C. |
|
2016 |
119 |
S1 |
p. S184-S185 2 p. |
artikel |
2088 |
SP-0520: The promises of dose painting
|
De Neve, W. |
|
2016 |
119 |
S1 |
p. S246-S247 2 p. |
artikel |
2089 |
SP-0396: The risk of cardiovascular disease after breast cancer treatment: the clinician's point of view
|
Taylor, C. |
|
2016 |
119 |
S1 |
p. S185-S186 2 p. |
artikel |
2090 |
SP-0099: The role of ATM and p53 in normal tissue radiation response
|
Kirsch, D. |
|
2016 |
119 |
S1 |
p. S46- 1 p. |
artikel |
2091 |
SP-0187: The role of dosimetry audit in safety, quality and best practice for external beam and brachytherapy
|
Palmer, A.L. |
|
2016 |
119 |
S1 |
p. S87- 1 p. |
artikel |
2092 |
SP-0186: The role of dosimetry audit in safety, quality and best practice for external beam and brachytherapy
|
Clark, C. |
|
2016 |
119 |
S1 |
p. S87- 1 p. |
artikel |
2093 |
SP-0105: The role of MRI in active surveillance
|
Villeirs, G. |
|
2016 |
119 |
S1 |
p. S48-S49 2 p. |
artikel |
2094 |
SP-0593: The role of the medical physicist in integrating quantitative imaging in RT: practical and organisational issues
|
Cattaneo, G.M. |
|
2016 |
119 |
S1 |
p. S284- 1 p. |
artikel |
2095 |
SP-0385: The study of therapy resistance in genetically engineered mouse models for BRCA1-mutated breast cancer
|
Rottenberg, S. |
|
2016 |
119 |
S1 |
p. S180-S181 2 p. |
artikel |
2096 |
SP-0012: The use of ACE inhibitors to attenuate thoracic irradiation-inducedcardiopulmonary toxicity.
|
Van der Veen, S.J. |
|
2016 |
119 |
S1 |
p. S5- 1 p. |
artikel |
2097 |
SP-0198: The way forward in organ preservation strategies for rectal cancer
|
Bach, S. |
|
2016 |
119 |
S1 |
p. S91- 1 p. |
artikel |
2098 |
SP-0320: The Young AIRO (Italian Association of Radiation Oncology) Group
|
Greto, D. |
|
2016 |
119 |
S1 |
p. S147- 1 p. |
artikel |
2099 |
SP-0318: The Young Radiation Oncology Group of EORTC -ROG
|
Kaidar-Person, O. |
|
2016 |
119 |
S1 |
p. S147- 1 p. |
artikel |
2100 |
SP-0626: This house believes that larger fraction sizes will be the standard-of-care for the majority of curative treatments by 2025
|
Yarnold, J.R. |
|
2016 |
119 |
S1 |
p. S296- 1 p. |
artikel |
2101 |
SP-0206: Tissue characterisation using quantitative radiomics
|
Van Elmpt, W. |
|
2016 |
119 |
S1 |
p. S94- 1 p. |
artikel |
2102 |
SP-0413: To use or not to use the LQ model at "high" radiation doses
|
Dörr, W. |
|
2016 |
119 |
S1 |
p. S192- 1 p. |
artikel |
2103 |
SP-0018: Towards a scoring system built on six distinct radiation-induced illnesses producing late gastrointestinal effects
|
Steineck, G. |
|
2016 |
119 |
S1 |
p. S7-S8 2 p. |
artikel |
2104 |
SP-0180: Trade off between standardisation and individualisation
|
Lievens, Y. |
|
2016 |
119 |
S1 |
p. S85- 1 p. |
artikel |
2105 |
SP-0595: Training in biological/functional imaging: lacks and opportunities
|
Torresin, A. |
|
2016 |
119 |
S1 |
p. S284-S285 2 p. |
artikel |
2106 |
SP-0315: Treatment choices in the elderly: focus on breast cancer
|
De Glas, N. |
|
2016 |
119 |
S1 |
p. S146- 1 p. |
artikel |
2107 |
SP-0194: Tumour-specific radiosensitisation by ATR inhibitors
|
Brunner, T. |
|
2016 |
119 |
S1 |
p. S90- 1 p. |
artikel |
2108 |
SP-0184: Underestimated importance of Intraluminal brachytherapy: bronchus, oesophageal, anorectal and hepatobiliary duct cancer
|
Skowronek, J. |
|
2016 |
119 |
S1 |
p. S87- 1 p. |
artikel |
2109 |
SP-0509: Validation of a prostate cancer decision aid tool for shared decision making
|
Bloemen- van Gurp, E.J. |
|
2016 |
119 |
S1 |
p. S240-S241 2 p. |
artikel |
2110 |
SP-0208: Validation of imaging with histology: implications for dose prescriptions
|
Ghobadi, G. |
|
2016 |
119 |
S1 |
p. S94- 1 p. |
artikel |
2111 |
SP-0025: Variation in DCE-MRI methodology and its implications for radiotherapy
|
Garpebring, A. |
|
2016 |
119 |
S1 |
p. S10- 1 p. |
artikel |
2112 |
SP-0573: VMAT QA: To do and not to do, those are the questions
|
Van de Kamer, J.B. |
|
2016 |
119 |
S1 |
p. S276- 1 p. |
artikel |
2113 |
SP-0614: What are the limits of minimally invasive surgery?
|
Zairi, F. |
|
2016 |
119 |
S1 |
p. S292- 1 p. |
artikel |
2114 |
SP-0491: What do we really see?
|
Zips, D. |
|
2016 |
119 |
S1 |
p. S234- 1 p. |
artikel |
2115 |
SP-0317: What is the Young ESTRO Committee and what can it do for young radiation oncology professionnals?
|
Bibault, J.E. |
|
2016 |
119 |
S1 |
p. S146-S147 2 p. |
artikel |
2116 |
SP-0233: What will we need for future RTQA in clinical trials?
|
Hurkmans, C. |
|
2016 |
119 |
S1 |
p. S106- 1 p. |
artikel |
2117 |
SP-0031: When to re-plan: a practical perspective
|
Bak, B. |
|
2016 |
119 |
S1 |
p. S12- 1 p. |
artikel |
2118 |
SP-0028: Which dosimetric uncertainties in small fields are clinically acceptable for IMRT/VMAT?
|
Georg, D. |
|
2016 |
119 |
S1 |
p. S10-S11 2 p. |
artikel |
2119 |
SP-0482: Whither fractionation?
|
Hoskin, P. |
|
2016 |
119 |
S1 |
p. S231- 1 p. |
artikel |
2120 |
SP-0587: Whole brain radiotherapy for brain metastases - the end of an era?
|
Mulvenna, P. |
|
2016 |
119 |
S1 |
p. S281-S282 2 p. |
artikel |
2121 |
Target displacement evaluation for fluoroscopic and four-dimensional cone-beam computed tomography
|
Iramina, H. |
|
2016 |
119 |
S1 |
p. S148- 1 p. |
artikel |
2122 |
Title Page
|
|
|
2016 |
119 |
S1 |
p. iv- 1 p. |
artikel |